PVLA

Kathleen Goin

Known title: Chief Operating OfficerCIK: 0001912570

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

Palvella Therapeutics Shares New Data at Dermatology Conference. Palvella Therapeutics presented three posters at the Fall Clinical Dermatology 2026 conference, sharing new data on microcystic lymphatic malformations and DSAP. This update highlights ongoing research in the company's key therapeutic areas. Meanwhile, HC Wainwright lowered its price target to $246 while maintaining its stance on the stock.

this person other insiders at PVLA

Transaction History

PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$251K
PVLA▼ Sell$151K
PVLA▼ Sell$253K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$227K
PVLA▼ Sell$303K
PVLA▼ Sell$61K
PVLA▼ Sell$16K
PVLA▼ Sell$47K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$77K
PVLA▼ Sell$154K
PVLA▼ Sell$287K
PVLA▼ Sell$125K
PVLA▼ Sell$3K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$264K
PVLA▼ Sell$210K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$371K
PVLA▼ Sell$99K
PVLA▼ Sell$5K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$72K
PVLA▼ Sell$83K
PVLA▼ Sell$13K
PVLA▼ Sell$189K
PVLA▼ Sell$191K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$267K
PVLA▼ Sell$205K
PVLA▼ Sell$36K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$240K
PVLA▼ Sell$102K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$53K
PVLA▼ Sell$367K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$415K
PVLA▼ Sell$129K
PVLA▲ Buy$15K
PVLA▲ Buy$20K
PVLA▼ Sell$242K

We use analytics to understand how market-wall is used. No personal data is sold.